Two-Dye Versus Three-Dye DIGE for Comparative Testis Tissue Proteomic Analysis von Holland, Ashling

Volltext

Label-free mass spectrometric analysis of the mdx-4cv diaphragm identifies the matricellular protein periostin as a potential factor involved in dystrophinopathy-related fibrosis von Holland, Ashling, Dowling, Paul, Meleady, Paula, Henry, Michael, Zweyer, Margit, Mundegar, Rustam R., Swandulla, Dieter, Ohlendieck, Kay

Volltext

Proteomic profiling of cardiomyopathic tissue from the aged mdx model of Duchenne muscular dystrophy reveals a drastic decrease in laminin, nidogen and annexin von Holland, Ashling, Dowling, Paul, Zweyer, Margit, Swandulla, Dieter, Henry, Michael, Clynes, Martin, Ohlendieck, Kay

Volltext

Comparative Label-Free Mass Spectrometric Analysis of Mildly versus Severely Affected mdx Mouse Skeletal Muscles Identifies Annexin, Lamin, and Vimentin as Universal Dystrophic Mar... von Holland, Ashling, Henry, Michael, Meleady, Paula, Winkler, Claudia K, Krautwald, Mirjam, Brinkmeier, Heinrich, Ohlendieck, Kay

Volltext

Comparative Testis Tissue Proteomics Using 2-Dye Versus 3-Dye DIGE Analysis von Holland, Ashling

Volltext

ECSIT is a critical limiting factor for cardiac function von Xu, Linan, Humphries, Fiachra, Delagic, Nezira, Wang, Bingwei, Holland, Ashling, Edgar, Kevin S., Hombrebueno, Jose R., Stolz, Donna Beer, Oleszycka, Ewa, Rodgers, Aoife M., Glezeva, Nadezhda, McDonald, Kenneth, Watson, Chris J., Ledwidge, Mark T., Ingram, Rebecca J., Grieve, David J., Moynagh, Paul N.

Volltext

Comparative profiling of the sperm proteome von Holland, Ashling, Ohlendieck, Kay

Volltext

Proteomic Profiling of the Dystrophin-Deficient mdx Phenocopy of Dystrophinopathy-Associated Cardiomyopathy von Holland, Ashling, Ohlendieck, Kay

Volltext

Pathoproteomic profiling of the skeletal muscle matrisome in dystrophinopathy associated myofibrosis von Holland, Ashling, Murphy, Sandra, Dowling, Paul, Ohlendieck, Kay

Volltext

PGN-EDO51: Preclinical Data Supporting the Development of an Enhanced Delivery Oligonucleotide (EDO) for the Treatment of Duchenne Muscular Dystrophy (DMD) (P3-8.002) von Holland, Ashling, Godfrey, Caroline, Lonkar, Pallavi, Svenstrup, Niels, Larkindale, Jane, McArthur, James, Bracegirdle, Sonia, Goyal, Jaya

Volltext

PGN-EDODM1: Preclinical Data Supporting the Development of an Enhanced Delivery Oligonucleotide (EDO) for the Treatment of Myotonic Dystrophy Type 1 (DM1) (S48.001) von Holland, Ashling, Klein, Arnaud, Godfrey, Caroline, Svenstrup, Niels, Larkindale, Jane, Bracegirdle, Sonia, Furling, Denis, Goyal, Jaya

Volltext

Design of a Phase 1, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Ascending Doses of PGN-EDODM1 in Adult Participan... von Mellion, Michelle, Larkindale, Jane, Cormier, Jennifer, Hand, Holly, Vacca, Sarah, Lonkar, Pallavi, Holland, Ashling, Garg, Brijesh, Foy, Jeff, McArthur, James

Volltext

Design of a phase 2 clinical program for the development of PGN-EDO51 in participants with duchenne muscular dystrophy (DMD) von Larkindale, Jane, Mellion, Michelle, Cormier, Jennifer, Vacca, Sarah, Shoskes, Jennifer, Lonkar, Pallavi, Holland, Ashling, Garg, Brijesh, Mcarthur, James

Volltext

Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice von Klein, Arnaud F, Varela, Miguel A, Arandel, Ludovic, Holland, Ashling, Naouar, Naira, Arzumanov, Andrey, Seoane, David, Revillod, Lucile, Bassez, Guillaume, Ferry, Arnaud, Jauvin, Dominic, Gourdon, Genevieve, Puymirat, Jack, Gait, Michael J, Furling, Denis, Wood, Matthew Ja

Volltext

PGN-EDO51, an Enhanced Delivery Oligonucleotide (EDO) for the Treatment of Duchenne Muscular Dystrophy (DMD): Results of a Phase 1 Study in Healthy Volunteers (P3-8.004) von Mellion, Michelle, Larkindale, Jane, Lonkar, Pallavi, Goyal, Jaya, Holland, Ashling, Foy, Jeff, Garg, Brijesh, Yu, Shaoxia, Frank, Anthony, Abbott, Chris, Svenstrup, Niels, Cormier, Jennifer, Vacca, Sarah, McArthur, James

Volltext

Positive results from a first-in-human study supporting continued development of PGN-EDO51 for the treatment of duchenne muscular dystrophy (DMD) von Larkindale, Jane, Mellion, Michelle, Lonkar, Pallavi, Goyal, Jaya, Holland, Ashling, Foy, Jeff, Garg, Brijesh, Yu, Shaoxia, Shoskes, Jennifer, Frank, Anthony, Abbott, Chris, Svendstrup, Niels, Cormier, Jennifer, Vacca, Sarah, Mcarthur, James

Volltext

Front cover: Pathoproteomic profiling of the skeletal muscle matrisome in dystrophinopathy associated myofibrosis von Holland, Ashling, Murphy, Sandra, Dowling, Paul, Ohlendieck, Kay

Volltext

Proteomic identification of muscle-associated biomarkers of amyotrophic lateral sclerosis using the wobbler mouse model of primary motor neuronopathy von Holland, Ashling, Ohlendieck, Kay

Volltext

Peptide-conjugated oligonucleotides evoke longlasting myotonic dystrophy correction in patient-derived cells and mice von Klein, Arnaud F, Varela, Miguel A, Arandel, Ludovic, Holland, Ashling, Naouar, Naira, Arzumanov, Andrey, Seoane, David, Revillod, Lucile, Bassez, Guillaume, Ferry, Arnaud, Jauvin, Dominic, Gourdon, Genevieve, Puymirat, Jack, Gait, Michael J, Furling, Denis, Wood, Matthew J A

Volltext

Correlation between serum reactivity to Demodex-associated Bacillus oleronius proteins, and altered sebum levels and Demodex populations in erythematotelangiectatic rosacea patient... von JARMUDA, Stanisław, MCMAHON, Fred, ZABA, Ryszard, O'REILLY, Niamh, JAKUBOWICZ, Oliwia, HOLLAND, Ashling, SZKARADKIEWICZ, Andrzej, KAVANAGH, Kevin

Volltext